The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...
Federal officials have approved new pain medication Journavx, designed to offer short-term pain relief without the addiction and overdose risks associated with opioids like Vicodin and OxyContin. The ...
Senate Judiciary Chairman Chuck Grassley of Iowa announced on Friday the introduction of a bill aimed at preventing opioid ...